The Devastating Impact of Chronic Fatigue

Chronic fatigue syndrome, also known as myalgic encephalomyelitis or ME/CFS, is a complex, debilitating condition characterized by profound fatigue that is not improved by rest and is worsened by physical or mental exertion. It affects an estimated 800,000 to 2.5 million Americans, many of whom are unable to work or participate in normal daily activities. The condition has gained renewed attention due to its significant overlap with long COVID symptoms.

Despite its prevalence, ME/CFS remains poorly understood and difficult to treat. No FDA-approved medications exist specifically for the condition. This has driven interest in hyperbaric oxygen therapy as a treatment that targets the biological abnormalities increasingly identified in ME/CFS patients.

The Biology Behind the Exhaustion

Research has identified several biological mechanisms that contribute to ME/CFS. Mitochondrial dysfunction impairs the cellular energy production that powers every process in the body. Neuroinflammation disrupts brain function, contributing to the cognitive difficulties patients call brain fog. Reduced cerebral blood flow deprives the brain of adequate oxygen. Immune dysregulation creates chronic low-grade inflammation. And autonomic nervous system dysfunction impairs the body's ability to regulate heart rate, blood pressure, and energy distribution.

HBOT addresses multiple mechanisms simultaneously. It provides the oxygen substrate mitochondria need to produce ATP, the cellular energy currency. It reduces neuroinflammation through anti-inflammatory pathways. It improves cerebral blood flow and stimulates new blood vessel growth in the brain. It modulates immune function. And it mobilizes stem cells that support tissue repair throughout the body.

Research and Clinical Experience

Clinical studies on HBOT for ME/CFS have shown improvements in fatigue severity, cognitive function including memory and concentration, sleep quality, exercise tolerance and post-exertional malaise, and overall quality of life scores. Brain imaging studies have demonstrated measurable increases in cerebral blood flow and metabolic activity in brain regions affected by ME/CFS. The overlap between ME/CFS and long COVID has also generated new research interest, as the biological mechanisms and symptom profiles are remarkably similar. Explore the evidence on our HBOT research library.

Treatment Protocol

HBOT for ME/CFS typically involves 40 to 60 sessions at 2.0 ATA, delivered five days per week. Each session lasts 60 to 90 minutes in a medical-grade chamber. Patients often begin with lower pressures and shorter sessions to minimize the risk of post-exertional symptom flares, gradually increasing as tolerated. Read about what to expect at your first session.

Treatment at National Hyperbaric

Our physicians, Dr. Allan Spiegel and Dr. Montana, understand the unique challenges faced by ME/CFS patients and design treatment protocols that respect the body's limitations while working to restore function. Contact us for a free consultation. Visit our cost and insurance page and our travel for treatment program. Explore all conditions we treat and our FAQ.